(0.25%) 5 144.25 points
(0.19%) 38 513 points
(0.35%) 17 909 points
(-0.54%) $83.40
(1.98%) $1.961
(0.05%) $2 348.40
(0.27%) $27.61
(0.85%) $929.95
(-0.22%) $0.933
(-0.25%) $11.00
(-0.30%) $0.798
(1.18%) $92.96
Quarter results today
(amc 2024-04-29)
Expected move: +/- 2.26%
-0.46% $ 335.61
Live Chart Being Loaded With Signals
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine...
Stats | |
---|---|
Tagesvolumen | 1.04M |
Durchschnittsvolumen | 1.27M |
Marktkapitalisierung | 127.62B |
EPS | $0 ( 2024-01-30 ) |
Nächstes Ertragsdatum | ( $2.35 ) 2024-05-06 |
Last Dividend | $0.750 ( 2023-09-28 ) |
Next Dividend | $0 ( N/A ) |
P/E | 40.63 |
ATR14 | $0.170 (0.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-21 | Stiles Spencer S | Buy | 203 | Common Stock |
2024-03-21 | Stiles Spencer S | Sell | 3 796 | Common Stock |
2024-03-21 | Stiles Spencer S | Sell | 203 | Dividend Equivalents |
2024-03-21 | Pierce James Andrew | Buy | 203 | Common Stock |
2024-03-21 | Pierce James Andrew | Sell | 4 412 | Common Stock |
INSIDER POWER |
---|
-59.40 |
Last 100 transactions |
Buy: 383 181 | Sell: 1 508 551 |
Volumen Korrelation
Stryker Corp Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Stryker Corp Korrelation - Währung/Rohstoff
Stryker Corp Finanzdaten
Annual | 2023 |
Umsatz: | $20.50B |
Bruttogewinn: | $13.06B (63.70 %) |
EPS: | $8.34 |
FY | 2023 |
Umsatz: | $20.50B |
Bruttogewinn: | $13.06B (63.70 %) |
EPS: | $8.34 |
FY | 2022 |
Umsatz: | $18.45B |
Bruttogewinn: | $11.58B (62.76 %) |
EPS: | $6.23 |
FY | 2021 |
Umsatz: | $17.11B |
Bruttogewinn: | $10.97B (64.11 %) |
EPS: | $5.31 |
Financial Reports:
No articles found.
Stryker Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.695 (N/A) |
$0.750 (N/A) |
$0.750 (N/A) |
$0.750 (N/A) |
$0.750 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.00150 | 1991-12-24 |
Last Dividend | $0.750 | 2023-09-28 |
Next Dividend | $0 | N/A |
Payout Date | 2023-10-31 | |
Next Payout Date | N/A | |
# dividends | 75 | -- |
Total Paid Out | $25.16 | -- |
Avg. Dividend % Per Year | 0.67% | -- |
Score | 5.39 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.08 | |
Div. Directional Score | 9.57 | -- |
Year | Amount | Yield |
---|---|---|
1991 | $0.00150 | 0.08% |
1992 | $0.00100 | 0.02% |
1993 | $0.00213 | 0.04% |
1994 | $0.00225 | 0.06% |
1995 | $0.00275 | 0.06% |
1996 | $0.00625 | 0.10% |
1997 | $0.0275 | 0.37% |
1998 | $0.00750 | 0.08% |
1999 | $0.0325 | 0.24% |
2000 | $0.0400 | 0.23% |
2001 | $0.0500 | 0.21% |
2002 | $0.0600 | 0.21% |
2003 | $0.0700 | 0.21% |
2004 | $0.0900 | 0.22% |
2005 | $0.110 | 0.23% |
2006 | $0.220 | 0.49% |
2007 | $0.330 | 0.60% |
2008 | $0.400 | 0.54% |
2009 | $0.250 | 0.61% |
2010 | $0.630 | 1.21% |
2011 | $0.753 | 1.38% |
2012 | $0.904 | 1.77% |
2013 | $1.100 | 1.97% |
2014 | $1.260 | 1.69% |
2015 | $1.415 | 1.51% |
2016 | $1.565 | 1.74% |
2017 | $1.745 | 1.46% |
2018 | $1.930 | 1.22% |
2019 | $2.14 | 1.38% |
2020 | $2.36 | 1.12% |
2021 | $2.59 | 1.08% |
2022 | $2.84 | 1.06% |
2023 | $2.25 | 0.92% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
ORC | Dividend Royal | 2023-11-29 | Monthly | 12 | 9.23% | 8.50 |
NCZ | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.79% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.154 | 1.500 | 6.91 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0793 | 1.200 | 7.36 | 8.83 | [0 - 0.3] |
returnOnEquityTTM | 0.179 | 1.500 | 9.12 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.360 | -1.000 | 6.40 | -6.40 | [0 - 1] |
currentRatioTTM | 1.580 | 0.800 | 7.10 | 5.68 | [1 - 3] |
quickRatioTTM | 0.861 | 0.800 | 9.64 | 7.71 | [0.8 - 2.5] |
cashRatioTTM | 0.375 | 1.500 | 9.03 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.326 | -1.500 | 4.57 | -6.86 | [0 - 0.6] |
interestCoverageTTM | 69.43 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 9.77 | 2.00 | 6.74 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 8.25 | 2.00 | 5.87 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.699 | -1.500 | 7.20 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.637 | 1.000 | 2.72 | 2.72 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.190 | 1.000 | 8.21 | 8.21 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.286 | 1.000 | 9.52 | 9.52 | [0.2 - 2] |
assetTurnoverTTM | 0.514 | 0.800 | 9.91 | 7.93 | [0.5 - 2] |
Total Score | 13.07 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 40.29 | 1.000 | 6.03 | 0 | [1 - 100] |
returnOnEquityTTM | 0.179 | 2.50 | 9.44 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 8.25 | 2.00 | 7.25 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.924 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 9.77 | 2.00 | 6.74 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.360 | 1.500 | 6.40 | -6.40 | [0 - 1] |
pegRatioTTM | 0.223 | 1.500 | -1.848 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.181 | 1.000 | 7.97 | 0 | [0.1 - 0.5] |
Total Score | 6.08 |
Stryker Corp
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.